scispace - formally typeset
H

Henry Völzke

Researcher at Greifswald University Hospital

Publications -  1093
Citations -  79204

Henry Völzke is an academic researcher from Greifswald University Hospital. The author has contributed to research in topics: Population & Study of Health in Pomerania. The author has an hindex of 115, co-authored 991 publications receiving 64260 citations. Previous affiliations of Henry Völzke include Group Health Cooperative & Umeå University.

Papers
More filters
Journal ArticleDOI

Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany.

TL;DR: The age-specific predicted risk of fatal CVD was consistently higher for men and women from SHIP than from KORA, and the recalibrated risk chart seems to be suited for use in German clinical practice.

A mega-analysis of genome-wide association studies for major depressive disorder

Stephan Ripke, +115 more
TL;DR: The authors conducted a genome-wide association studies (GWASA) mega-analysis for major depressive disorder (MDD) and found that only 15 SNPs exceeded genomewide significance (P<5 x 10(-8)), and all were in a 248 kb interval of high LD on 3p21.1 (chr3:52 425 083-53 822 102, minimum P=5.9 x 10−9) at rs2535629).
Journal ArticleDOI

High Serum Thyrotropin Levels Are Associated with Current But Not with Incident Hypertension

TL;DR: High serum TSH levels were associated with current hypertension and blood pressure but not with a five-year change in blood pressure and incident hypertension, arguing for only a short-term effect of thyroid hormone levels on arterial blood pressure or a spurious association that needs further evaluation in population-based studies.
Journal ArticleDOI

Incremental Effects of Endocrine and Metabolic Biomarkers and Abdominal Obesity on Cardiovascular Mortality Prediction

TL;DR: HbA1c, IGF-1, and hsCRP predict cardiovascular death independently of conventional cardiovascular risk factors, and these easily assessed endocrine and metabolic biomarkers might improve the ability to predict cardiovascularDeath.